Alantos Pharmaceuticals Holding - Ownership and Business Overview

Life ScienceCompany

Alantos Pharmaceuticals Holding Ownership

Who owns Alantos Pharmaceuticals Holding?

Alantos Pharmaceuticals Holding is owned by Amgen. It was acquired on June 6, 2007.

Alantos Pharmaceuticals Holding Business Overview

Where is Alantos Pharmaceuticals Holding headquartered?

Alantos Pharmaceuticals Holding is headquartered in Cambridge, Massachusetts.

How many employees does Alantos Pharmaceuticals Holding have?

Alantos Pharmaceuticals Holding has 45 employees.

What sector is Alantos Pharmaceuticals Holding in?

Alantos Pharmaceuticals Holding is a life science company.

When was Alantos Pharmaceuticals Holding founded?

Alantos Pharmaceuticals Holding was founded in 1999.

Life Science M&A Summary in 2007

Out of 60 sectors in the Mergr database, life science ranked 10 in number of deals in 2007. The largest life science acquisition in 2007 was Organon BioSciences N.V. - which was acquired by Schering-Plough for $12.4B.

Join Mergr to view all 131 acquisitions of life science companies in 2007, including 29 acquisitions by private equity firms, and 102 by strategics.

Alantos Pharmaceuticals Holding, Inc.

Riverside Technology Center,840 Memorial Drive,2nd Floor,
Cambridge, Massachusetts 02139
United States,
(617)577-0011

Alantos Pharmaceuticals is a chemistry-driven biopharmaceutical company with a proprietary pipeline of small molecule drugs focused in the area of type II diabetes and osteoarthritis / inflammation. With locations in Cambridge, Massachusetts and Heidelberg, Germany, Alantos Pharmaceuticals employs 45 people.


 Subscribe to unlock this and 206,153
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.